These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 12428206)

  • 1. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency.
    Simard J; Moisan AM; Morel Y
    Semin Reprod Med; 2002 Aug; 20(3):255-76. PubMed ID: 12428206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.
    Simard J; Ricketts ML; Gingras S; Soucy P; Feltus FA; Melner MH
    Endocr Rev; 2005 Jun; 26(4):525-82. PubMed ID: 15632317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes.
    Moisan AM; Ricketts ML; Tardy V; Desrochers M; Mébarki F; Chaussain JL; Cabrol S; Raux-Demay MC; Forest MG; Sippell WG; Peter M; Morel Y; Simard J
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4410-25. PubMed ID: 10599696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency.
    Simard J; Ricketts ML; Moisan AM; Tardy V; Peter M; Van Vliet G; Morel Y
    Endocr Res; 2000 Nov; 26(4):761-70. PubMed ID: 11196452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency.
    Simard J; Rhéaume E; Sanchez R; Laflamme N; de Launoit Y; Luu-The V; van Seters AP; Gordon RD; Bettendorf M; Heinrich U
    Mol Endocrinol; 1993 May; 7(5):716-28. PubMed ID: 8316254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.
    Rhéaume E; Simard J; Morel Y; Mebarki F; Zachmann M; Forest MG; New MI; Labrie F
    Nat Genet; 1992 Jul; 1(4):239-45. PubMed ID: 1363812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues.
    Labrie F; Simard J; Luu-The V; Bélanger A; Pelletier G
    J Steroid Biochem Mol Biol; 1992 Dec; 43(8):805-26. PubMed ID: 22217825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.
    Lutfallah C; Wang W; Mason JI; Chang YT; Haider A; Rich B; Castro-Magana M; Copeland KC; David R; Pang S
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2611-22. PubMed ID: 12050224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia.
    Pang S; Wang W; Rich B; David R; Chang YT; Carbunaru G; Myers SE; Howie AF; Smillie KJ; Mason JI
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2556-63. PubMed ID: 12050213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxyl-terminal mutations in 3beta-hydroxysteroid dehydrogenase type II cause severe salt-wasting congenital adrenal hyperplasia.
    Welzel M; Wüstemann N; Simic-Schleicher G; Dörr HG; Schulze E; Shaikh G; Clayton P; Grötzinger J; Holterhus PM; Riepe FG
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1418-25. PubMed ID: 18252794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel homozygous nonsense mutations E135* in the type II 3beta-hydroxysteroid dehydrogenase gene in a girl with salt-losing congenital adrenal hyperplasia. Mutations in brief no. 168. Online.
    Marui S; Torrealba IM; Russell AJ; Latronico AC; Sutcliffe RG; Mendonca BB
    Hum Mutat; 1998; 12(2):139. PubMed ID: 10694926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping.
    Mermejo LM; Elias LL; Marui S; Moreira AC; Mendonca BB; de Castro M
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1287-93. PubMed ID: 15585552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel A10E homozygous mutation in the HSD3B2 gene causing severe salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46,XX and 46,XY French-Canadians: evaluation of gonadal function after puberty.
    Alos N; Moisan AM; Ward L; Desrochers M; Legault L; Leboeuf G; Van Vliet G; Simard J
    J Clin Endocrinol Metab; 2000 May; 85(5):1968-74. PubMed ID: 10843183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of 3beta-hydroxysteroid dehydrogenase type II (HSD3B2) deficiency picked up by neonatal screening for 21-hydroxylase deficiency: difficulties and delay in etiologic diagnosis.
    Nordenström A; Forest MG; Wedell A
    Horm Res; 2007; 68(4):204-8. PubMed ID: 17496421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia.
    Schneider G; Genel M; Bongiovanni AM; Goldman AS; Rosenfield RL
    J Clin Invest; 1975 Apr; 55(4):681-90. PubMed ID: 164481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads.
    Rhéaume E; Lachance Y; Zhao HF; Breton N; Dumont M; de Launoit Y; Trudel C; Luu-The V; Simard J; Labrie F
    Mol Endocrinol; 1991 Aug; 5(8):1147-57. PubMed ID: 1944309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function relationships of 3 beta-hydroxysteroid dehydrogenase: contribution made by the molecular genetics of 3 beta-hydroxysteroid dehydrogenase deficiency.
    Morel Y; Mébarki F; Rhéaume E; Sanchez R; Forest MG; Simard J
    Steroids; 1997 Jan; 62(1):176-84. PubMed ID: 9029734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency.
    Sanchez R; Rhéaume E; Laflamme N; Rosenfield RL; Labrie F; Simard J
    J Clin Endocrinol Metab; 1994 Mar; 78(3):561-7. PubMed ID: 8126127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
    Zhang L; Sakkal-Alkaddour H; Chang YT; Yang X; Pang S
    J Clin Endocrinol Metab; 1996 Jan; 81(1):291-5. PubMed ID: 8550766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency.
    Simard J; Rheaume E; Mebarki F; Sanchez R; New MI; Morel Y; Labrie F
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):127-38. PubMed ID: 7626445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.